Radicle GI Health RAATM: A Study Assessing the Impact of Health and Wellness Products on Gastrointestinal-Related Quality of Life and Related Health Outcomes

ConditionDigestion-associated Quality of Life

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age21-105

SponsorRadicle Science

About this trial

Radicle GI Health RAA: A randomized, double-blind, placebo- controlled direct-to-consumer study assessing the impact of health and wellness products on gastrointestinal-related quality of life and related health outcomes.

Eligibility criteria

Qualifiers

Adults, at least 21 years of age at the time of electronic consent, inclusive of all ethnicities, races, and gender identities

Assigned sex at birth will determine sex-specific recruitment and PROs (male vs female) employed, when needed

Resides in the United States

Has the opportunity for at least 30% improvement in their primary health outcome

Disqualifiers

None

Trial design

Treatments tested in this trial

Placebo GI Health Control
Active GI Health Product 1

Treatment groups

550 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Radicle Science

Lead sponsor

Source ClinicalTrials.gov